Is Boston Scientific Stock a Good Investment?
Boston Scientific Investment Advice | BSX |
- Examine Boston Scientific's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Boston Scientific's leadership team and their track record. Good management can help Boston Scientific navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Boston Scientific's business and its evolving consumer preferences.
- Compare Boston Scientific's performance and market position to its competitors. Analyze how Boston Scientific is positioned in terms of product offerings, innovation, and market share.
- Check if Boston Scientific pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Boston Scientific's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Boston Scientific Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Boston Scientific Corp is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Very Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Boston Scientific Stock
Researching Boston Scientific's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 92.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.65. Boston Scientific Corp had not issued any dividends in recent years. The entity had 2:1 split on the 6th of November 2003.
To determine if Boston Scientific is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Boston Scientific's research are outlined below:
| Boston Scientific is unlikely to experience financial distress in the next 2 years | |
| Boston Scientific has a very strong financial position based on the latest SEC filings | |
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from zacks.com: Why Is Zimmer Up 4.8 percent Since Last Earnings Report |
Boston Scientific Quarterly Good Will |
|
Boston Scientific uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Boston Scientific Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Boston Scientific's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Boston Scientific's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Boston Scientific's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2013-10-24 | 2013-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2013-04-25 | 2013-03-31 | 0.09 | 0.1 | 0.01 | 11 | ||
2012-07-26 | 2012-06-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2012-04-19 | 2012-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
2007-07-20 | 2007-06-30 | 0.09 | 0.08 | -0.01 | 11 | ||
2006-10-18 | 2006-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2002-04-16 | 2002-03-31 | 0.1 | 0.11 | 0.01 | 10 | ||
2001-10-22 | 2001-09-30 | 0.09 | 0.1 | 0.01 | 11 |
Know Boston Scientific's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Boston Scientific is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Boston Scientific Corp backward and forwards among themselves. Boston Scientific's institutional investor refers to the entity that pools money to purchase Boston Scientific's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main | 2024-09-30 | 21.8 M | Capital World Investors | 2024-09-30 | 21.7 M | Bollard Group Llc | 2024-06-30 | 21.7 M | Hhg Plc | 2024-06-30 | 18.3 M | Norges Bank | 2024-06-30 | 17.9 M | Franklin Resources Inc | 2024-09-30 | 15.9 M | Amundi | 2024-06-30 | 15.4 M | Bank Of New York Mellon Corp | 2024-06-30 | 14.8 M | Legal & General Group Plc | 2024-06-30 | 13.9 M | Fmr Inc | 2024-09-30 | 135.2 M | Vanguard Group Inc | 2024-09-30 | 131.3 M |
Boston Scientific's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 133.62 B.Market Cap |
|
Boston Scientific's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.11 | 0.11 | |
| Return On Capital Employed | 0.08 | 0.14 | |
| Return On Assets | 0.05 | 0.05 | |
| Return On Equity | 0.08 | 0.06 |
Determining Boston Scientific's profitability involves analyzing its financial statements and using various financial metrics to determine if Boston Scientific is a good buy. For example, gross profit margin measures Boston Scientific's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Boston Scientific's profitability and make more informed investment decisions.
Boston Scientific's Earnings Breakdown by Geography
Please note, the imprecision that can be found in Boston Scientific's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Boston Scientific Corp. Check Boston Scientific's Beneish M Score to see the likelihood of Boston Scientific's management manipulating its earnings.
Evaluate Boston Scientific's management efficiency
Boston Scientific Corp has Return on Asset of 0.049 % which means that on every $100 spent on assets, it made $0.049 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0892 %, implying that it generated $0.0892 on every 100 dollars invested. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Boston Scientific's Return On Tangible Assets are fairly stable compared to the past year. Return On Capital Employed is likely to rise to 0.14 in 2024, whereas Return On Equity is likely to drop 0.06 in 2024. At this time, Boston Scientific's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 30.1 B in 2024, whereas Other Current Assets are likely to drop slightly above 544.2 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 13.44 | 14.11 | |
| Tangible Book Value Per Share | (0.59) | (0.62) | |
| Enterprise Value Over EBITDA | 26.82 | 14.59 | |
| Price Book Value Ratio | 4.36 | 5.87 | |
| Enterprise Value Multiple | 26.82 | 14.59 | |
| Price Fair Value | 4.36 | 5.87 | |
| Enterprise Value | 61.2 B | 64.2 B |
Leadership at Boston Scientific emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Beta 0.797 |
Basic technical analysis of Boston Stock
As of the 30th of November, Boston Scientific shows the Risk Adjusted Performance of 0.1591, mean deviation of 0.7392, and Downside Deviation of 0.8609. Boston Scientific Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Boston Scientific's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Boston Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Boston Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Boston Scientific insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Joseph Fitzgerald few days ago Disposition of 11236 shares by Joseph Fitzgerald of Boston Scientific subject to Rule 16b-3 | ||
Arthur Butcher few days ago Disposition of 14010 shares by Arthur Butcher of Boston Scientific at 89.2694 subject to Rule 16b-3 | ||
Wendy Carruthers over two months ago Disposition of 1197 shares by Wendy Carruthers of Boston Scientific at 24.55 subject to Rule 16b-3 | ||
Wendy Carruthers over six months ago Disposition of 6983 shares by Wendy Carruthers of Boston Scientific at 66.89 subject to Rule 16b-3 | ||
Daniel Brennan over six months ago Disposition of 1644 shares by Daniel Brennan of Boston Scientific at 65.82 subject to Rule 16b-3 | ||
Tobin James R over a year ago Exercise or conversion by Tobin James R of 100000 shares of Boston Scientific subject to Rule 16b-3 |
Boston Scientific's Outstanding Corporate Bonds
Boston Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Boston Scientific Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Boston bonds can be classified according to their maturity, which is the date when Boston Scientific Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAZ73 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAY09 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAX26 | View | |
| BXP 675 01 DEC 27 Corp BondUS10112RBG83 | View | |
| BOSTON SCIENTIFIC P Corp BondUS101137AL15 | View |
Understand Boston Scientific's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Boston Scientific's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1591 | |||
| Market Risk Adjusted Performance | 0.4879 | |||
| Mean Deviation | 0.7392 | |||
| Semi Deviation | 0.6301 | |||
| Downside Deviation | 0.8609 | |||
| Coefficient Of Variation | 487.5 | |||
| Standard Deviation | 0.9929 | |||
| Variance | 0.9859 | |||
| Information Ratio | 0.0665 | |||
| Jensen Alpha | 0.142 | |||
| Total Risk Alpha | 0.0279 | |||
| Sortino Ratio | 0.0767 | |||
| Treynor Ratio | 0.4779 | |||
| Maximum Drawdown | 5.62 | |||
| Value At Risk | (1.19) | |||
| Potential Upside | 1.58 | |||
| Downside Variance | 0.7411 | |||
| Semi Variance | 0.397 | |||
| Expected Short fall | (0.84) | |||
| Skewness | 0.5133 | |||
| Kurtosis | 2.68 |
| Risk Adjusted Performance | 0.1591 | |||
| Market Risk Adjusted Performance | 0.4879 | |||
| Mean Deviation | 0.7392 | |||
| Semi Deviation | 0.6301 | |||
| Downside Deviation | 0.8609 | |||
| Coefficient Of Variation | 487.5 | |||
| Standard Deviation | 0.9929 | |||
| Variance | 0.9859 | |||
| Information Ratio | 0.0665 | |||
| Jensen Alpha | 0.142 | |||
| Total Risk Alpha | 0.0279 | |||
| Sortino Ratio | 0.0767 | |||
| Treynor Ratio | 0.4779 | |||
| Maximum Drawdown | 5.62 | |||
| Value At Risk | (1.19) | |||
| Potential Upside | 1.58 | |||
| Downside Variance | 0.7411 | |||
| Semi Variance | 0.397 | |||
| Expected Short fall | (0.84) | |||
| Skewness | 0.5133 | |||
| Kurtosis | 2.68 |
Consider Boston Scientific's intraday indicators
Boston Scientific intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Boston Scientific stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Boston Scientific Corporate Filings
F4 | 27th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 1st of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F3 | 30th of July 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Boston Stock media impact
Far too much social signal, news, headlines, and media speculation about Boston Scientific that are available to investors today. That information is available publicly through Boston media outlets and privately through word of mouth or via Boston internal channels. However, regardless of the origin, that massive amount of Boston data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Boston Scientific news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Boston Scientific relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Boston Scientific's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Boston Scientific alpha.
Boston Scientific Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Boston Scientific can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Boston Scientific Corp Historical Investor Sentiment
Investor biases related to Boston Scientific's public news can be used to forecast risks associated with an investment in Boston. The trend in average sentiment can be used to explain how an investor holding Boston can time the market purely based on public headlines and social activities around Boston Scientific Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Boston Scientific's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Boston Scientific and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Boston Scientific news discussions. The higher the estimate score, the more favorable the investor's outlook on Boston Scientific.
Boston Scientific Corporate Directors
| Edward Ludwig | Lead Independent Director | Profile | |
| Donna James | Independent Director | Profile | |
| Stephen MacMillan | Independent Director | Profile | |
| Ellen Zane | Independent Director | Profile |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.